2784.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

Stats
Объем за сегодня	958 800
Средний объем	440 903
Рыночная капитализация	428.87B
EPS	¥0 ( 2024-02-07 )
Дата следующего отчета о доходах	( ¥38.32 ) 2024-05-13
Last Dividend	¥29.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	14.16
ATR14	¥1.428 (0.06%)

Объем Корреляция

Длинно: 0.00 (neutral)

Кратко: -0.51 (weak negative)

Signal:(39.899) Neutral

Alfresa Holdings Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Alfresa Holdings Корреляция - Валюта/Сырье

0.05
( neutral )

-0.17
( neutral )

0.08
( neutral )

0.41
( neutral )

-0.21
( neutral )

-0.11
( neutral )

Alfresa Holdings Финансовые показатели

Annual	2022
Выручка:	¥2 696.07B
Валовая прибыль:	¥192.09B (7.12 %)
EPS:	¥127.42

FY	2022
Выручка:	¥2 696.07B
Валовая прибыль:	¥192.09B (7.12 %)
EPS:	¥127.42

FY	2022
Выручка:	¥2 585.64B
Валовая прибыль:	¥187.47B (7.25 %)
EPS:	¥153.57

FY	2021
Выручка:	¥2 603.26B
Валовая прибыль:	¥175.54B (6.74 %)
EPS:	¥115.75

Financial Reports:

No articles found.

Alfresa Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥28.00 (N/A)	¥0 (N/A)	¥29.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Alfresa Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.92%) | Divividend Growth Potential Score: 3.50 - Decrease likely (29.97%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥8.75	2006-03-28
Last Dividend	¥29.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	36	--
Total Paid Out	¥544.25	--
Avg. Dividend % Per Year	0.00%	--
Score	3.32	--
Div. Sustainability Score	9.59
Div.Growth Potential Score	3.50
Div. Directional Score	6.55	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8537.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7860.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7003.T	Ex Dividend Junior	2024-03-28	Sporadic	0.00%
6356.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5210.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
4318.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3482.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
2695.T	Ex Dividend Junior	2023-10-30	Annually	0.00%
9065.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8151.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0113	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0212	1.200	9.29	10.00	[0 - 0.3]
returnOnEquityTTM	0.0671	1.500	-0.365	-0.548	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.213	0.800	8.94	7.15	[1 - 3]
quickRatioTTM	0.923	0.800	9.28	7.42	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0.0200	-1.500	9.67	-10.00	[0 - 0.6]
interestCoverageTTM	488.93	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0646	-1.500	9.74	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0724	1.000	-2.13	-2.13	[0.2 - 0.8]
operatingProfitMarginTTM	0.0142	1.000	-1.716	-1.716	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.897	1.000	6.13	6.13	[0.2 - 2]
assetTurnoverTTM	1.885	0.800	0.766	0.613	[0.5 - 2]
Total Score				9.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.49	1.000	8.74	0	[1 - 100]
returnOnEquityTTM	0.0671	2.50	-0.235	-0.548	[0.1 - 1.5]
freeCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.436	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.413	1.500	-0.582	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.00951	1.000	-2.26	0	[0.1 - 0.5]
Total Score				3.50

Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.